Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | TRAWS PHARMA, INC PAR TRAW | Perceptive Advisors LLC | 886,887 9.990% | 341,690 (+62.67%) | Filing History |
| 2025-11-14 4:00 pm Sale | 2025-09-30 | 13G | ARTIVION, INC. AORT | Perceptive Advisors LLC | 2,020,000 4.300% | -363,978 (-15.27%) | Filing History |
| 2025-11-14 4:00 pm Purchase | 2025-09-30 | 13G | AMYLYX PHARMACEUTICALS INC AMLX | Perceptive Advisors LLC | 8,952,365 8.200% | 1,078,017 (+13.69%) | Filing History |
| 2025-11-13 5:05 pm Sale | 2025-11-11 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 138,885 7.800% | -45,875 (-24.83%) | Filing History |
| 2025-11-10 5:07 pm Sale | 2025-11-06 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 184,760 11.200% | -70,990 (-27.76%) | Filing History |
| 2025-11-03 4:09 pm Purchase | 2025-10-27 | 13G | X4 PHARMACEUTICALS INC XFOR | Perceptive Advisors LLC | 6,064,680 7.600% | 6,064,680 (New Position) | Filing History |
| 2025-10-24 7:30 pm Purchase | 2025-10-23 | 13D | TRINITY BIOTECH PLC SPONSORED TRIB | Perceptive Advisors LLC | 3,360,000 22.500% | 2,788,000 (+487.41%) | Filing History |
| 2025-10-16 8:52 pm Unchanged | 2025-10-14 | 13D | ASTRIA THERAPEUTICS INC ATXS | Perceptive Advisors LLC | 6,485,420 11.500% | 0 (Unchanged) | Filing History |
| 2025-10-14 09:24 am Purchase | 2025-10-06 | 13G | TRAVERE THERAPEUTICS INC TVTX | Perceptive Advisors LLC | 4,895,615 5.500% | 3,050,060 (+165.27%) | Filing History |
| 2025-10-10 12:50 pm Purchase | 2025-10-03 | 13G | ALTO NEUROSCIENCE INC ANRO | Perceptive Advisors LLC | 1,989,393 7.300% | 1,989,393 (New Position) | Filing History |
| 2025-10-09 4:00 pm Purchase | 2025-10-02 | 13G | PALISADE BIO INC COM P PALI | Perceptive Advisors LLC | 12,243,018 9.990% | 12,243,018 (New Position) | Filing History |
| 2025-09-11 4:02 pm Purchase | 2025-09-04 | 13G | KALA BIO, INC. KALA | Perceptive Advisors LLC | 10,875 7.700% | 10,875 (New Position) | Filing History |
| 2025-08-21 4:00 pm Purchase | 2025-08-14 | 13G | CYTOMX THERAPEUTICS INC CTMX | Perceptive Advisors LLC | 9,680,185 5.900% | 7,103,142 (+275.63%) | Filing History |
| 2025-08-14 5:21 pm Purchase | 2025-08-12 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 255,750 15.550% | 599 (+0.23%) | Filing History |
| 2025-08-14 5:20 pm Sale | 2025-06-30 | 13G | ONKURE THERAPEUTICS, INC. CLAS OKUR | Perceptive Advisors LLC | 0 0.000% | -1,004,439 (Position Closed) | Filing History |
| 2025-08-14 4:26 pm Sale | 2025-06-30 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | Perceptive Advisors LLC | 699,486 3.200% | -741,763 (-51.47%) | Filing History |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | AMICUS THERAPEUTICS INC FOLD | Perceptive Advisors LLC | 7,412,830 2.400% | -14,051,697 (-65.46%) | Filing History |
| 2025-08-14 4:25 pm Sale | 2025-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Perceptive Advisors LLC | 4,639,949 4.400% | -1,755,597 (-27.45%) | Filing History |
| 2025-08-14 4:23 pm Sale | 2025-06-30 | 13G | ANTERIS TECHNOLOGIES GLOBAL CO AVR | Perceptive Advisors LLC | 1,705,130 4.700% | -734,870 (-30.12%) | Filing History |
| 2025-08-14 4:23 pm Sale | 2025-06-30 | 13G | EVOLUS INC EOLS | Perceptive Advisors LLC | 2,474,843 3.800% | -1,654,299 (-40.06%) | Filing History |